Navigation Links
Conference report highlights new research into drug delivery to treat eye disease
Date:11/17/2008

itive polymers to help deliver one of the latest drugs, silencing RNA (siRNA).

Another group of presenters discussed the use of nanoparticles, microbeads and microneedles. Mansoor M. Amiji, PhD, said that nanoparticles can help overcome barriers to drug delivery from the organ level to the subcellular level. Another research laboratory was investigating the effectiveness of hollow and solid microneedles that penetrate only hundreds of micrometers into the cornea or sclera to deliver drugs.

A safer alternative to direct intravitreous injections might be transscleral delivery into the vitreous using subconjunctival injections, said Michael Robinson, MD, adding that researchers needed a clear understanding of the dynamic barriers for the technique to work in treating retinal diseases. Another researcher in this area, Dayle H. Geroski, PhD, suggested that the relatively high permeability of the sclera offers great potential for transscleral drug delivery, especially for administration to the posterior part of the eye.

Other research focused on photodynamic therapy, which uses a photosensitizer agent that localizes more or less selectively to the target tissue and is activated by light, triggering chemical reactions that injure the target tissue.


'/>"/>

Contact: Jo Olson
jolson@arvo.org
240-221-2923
Association for Research in Vision and Ophthalmology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
5. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
7. AtriCure to Present at Roth Capital Partners 2007 New York Conference
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. MDS to Present at Thomas Weisel Partners Healthcare Conference
10. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
11. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...inds differences in mood despite similar weight lo...- Both a high-fat, low-carbohydrate diet such as t... diet appear to help people lose pounds over the c...ow-fat diets will result in long-term improvement ...of Archives of Internal Medicine . , People on...
(Date:11/9/2009)... Fast food chains are often blamed for the inc...by Fitness.com.au however finds that 80% of people...lity. , (PRWEB) November ...deo games were behind Australia’s obesity ep...st innocent bystanders. A recent survey commission...
(Date:11/9/2009)...mprehensive Cancer Network (NCCN) has posted a dra...raft paradigm for near-term comparative effectiven... The document introduces the NCCN Comparative Ther... that compares the risk-versus-benefit of differen...al Practice Guidelines in Oncology(TM). The paper ...
(Date:11/9/2009)... Highlighting a commitment to prov...ced entertainment and digital display technology o...ng-Term Care and Hospital Grade LCD HDTVs this wee... Aging 2009 annual meeting and exposition (booth #...e of "HealthView(TM)" Long-Term Care LCD HDTVs bri...
(Date:11/9/2009)...uestion of why this is so, however , ,...tomy, women with very dense breasts have a higher ...a new study shows. , Breast density has already...breast cancer, and experts have suspected that ver...reased risk of cancer recurrence at the site of th...
Breaking Medicine News(10 mins):Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Fitness.com.au Poll Finds 80% Blame Parents For Our Overweight Kids 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 5Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3
..., Despite the commitments...lized training and practicing medicine in fields o... Honors College at Indiana University of Pennsylva...tients with different needs to Rebecca Pounds, who...
..., Chief Medical Officer, ... 2nd Annual Public Healthcare congress in Washingt...resentation, "Lessons Learned; Implementing a...ciency and security of patient information exchang...
..., Medical and nursing scr...ly redesigned site. With new products added and a ...ecoming the leading destination for hospital unifo...s new user friendly website. The new site has impl...
..., INDIANAPOLIS Public health professionals from...ianapolis for a national summit on ethical and pol...e medical community while preparing for a large-sc...Health, the Indiana University Center for Bioethic...
...Bipartisan Bill Improves Low-Income Help and Boost...Helps Ensure Access to Doctors, NEW YORK, July 15... and Senate voted overwhelmingly to override a,Whi...grams, boost health care quality with a system of ...
...OPTOMETRISTS LEAD WINNING PATIENT ACCESS COALITION...sociation (AOA) applauds Members of Congress from ...,s veto of legislation passed to stop massive,cuts... safeguard patient,access to eye and vision care t...
Other Medicine News:Health News:Robert E Cook Honors College Women In Medicine 2Health News:Robert E Cook Honors College Women In Medicine 3Health News:Robert E Cook Honors College Women In Medicine 4Health News:Robert E Cook Honors College Women In Medicine 5Health News:Robert E Cook Honors College Women In Medicine 6Health News:Orion Health's Dr. Chris Hobson Selected to Speak at World Congress Public Health Conference 2Health News:Orion Health's Dr. Chris Hobson Selected to Speak at World Congress Public Health Conference 3Health News:Medical And Nursing Scrubs Retailer Blue Sky Scrubs Unveils New Website 2Health News:Confronting Ethics of Pandemic Influenza Planning: 2008 Summit of the States 2Health News:AARP NY Thanks Congress for Keeping Medicare Fair, Overriding White House Veto 2Health News:AARP NY Thanks Congress for Keeping Medicare Fair, Overriding White House Veto 3Health News:American Optometric Association Applauds Override of Medicare Cuts 2Health News:American Optometric Association Applauds Override of Medicare Cuts 3
(Date:11/9/2009)... Facet Solutions, Inc. today announced that it has...trolled ACADIA(TM) IDE study for lumbar spinal ste...009," stated President and CEO, Geoff Pardo. "It i...omes that surgeons are seeing, and the ease with w...on people are diagnosed with lumbar spinal stenosi...
(Date:11/9/2009).... 9 Hill-Rom (NYSE: H...tion of a joint venture that will focus on the sal...face replacement systems that are intended to be s...for surfaces that are technologically obsolete or ...al leader in patient support systems and related t...
(Date:11/9/2009)...e/ -- Momentum is building for the early December...ond P-MEC India pharma ingredients, services and t...exhibitors from over 80 countries are expected...ts, being held on 1 - 3 December. ,, In additi...lude two new launches. BioPh India will focus on...
Breaking Medicine Technology:Facet Solutions Enrolls 100th Patient in US Pivotal IDE Study 2Hill-Rom and Encompass Group Form Joint Venture 2Hill-Rom and Encompass Group Form Joint Venture 3Hill-Rom and Encompass Group Form Joint Venture 4Hill-Rom and Encompass Group Form Joint Venture 5Forecast Looks Good for India Pharma Shows 2Forecast Looks Good for India Pharma Shows 3While you were sleeping 47771 1While you were sleeping 47771 2Natura Therapeutics and USF receive NIH grant to study green tea compound for Alzheimers 47769 1Natura Therapeutics and USF receive NIH grant to study green tea compound for Alzheimers 47769 2ESC Congress 2009 3A Worlds biggest cardiology meeting to be held in Barcelona 47767 1ESC Congress 2009 3A Worlds biggest cardiology meeting to be held in Barcelona 47767 2
...R-132 could provide a new therapeutic approach for...er, QUEBEC CITY, April 17, 2007 /PRNewswire-FirstC... biopharmaceutical company,focused on endocrine th...tlining in vivo data for its growth hormone-releas...ncer, at the American,Association for Cancer Resea...
...As previously announced, primary endpoint not met;...study treatment with ERBITUX,-, NEW YORK, April 16...ncorporated and Bristol-Myers Squibb Company today...a randomized,open-label, multi-center Phase III t...tecan to irinotecan alone in patients with,metasta...
Other Medicine Technology:AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 2Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 5Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 6Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 8Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 9
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
Medicine Products: